Blood test for early diagnosis of colorectal cancer
Official title: Development and Validation of a Blood Test for Early Diagnosis of Colorectal Cancer Based on Molecular Markers and Risk Factors Identified With Artificial Intelligence Tools
Run by Advanced Marker Discovery S.l. · NCT06889883 · Data updated 2026-11-12
This study is testing a new blood test to see if it can help find colorectal cancer and advanced polyps earlier in people who are at risk.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 510 (estimated) |
| Sponsor | Advanced Marker Discovery S.l. Industry-sponsored |
| Drugs / interventions | chemotherapy |
| Locations | 9 sites (Zaragoza, Aragon and 8 other locations) |
| Status | Recruiting |
| Started | June 6, 2023 |
| Main results expected | December 31, 2025 |
| Study ends | December 31, 2025 |
| Registry record updated | October 1, 2025 |
| Trial ID | NCT06889883 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults over 18 who are scheduled for colonoscopy or surgical resection due to suspected colorectal cancer.
✕Probably not a fit
Patients with a history of cancer in the past 5 years or those with certain benign conditions like non-advanced adenomas will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to develop and validate a blood test that combines molecular markers in plasma with risk factors and clinical data to improve early diagnosis of colorectal cancer and advanced adenomas. It involves a multicenter, case-control design where patients undergoing colonoscopy or surgical resection will be compared to healthy individuals. The goal is to create an optimized algorithm that enhances the accuracy of early detection.
Why it matters
Potential benefit: If successful, this blood test could lead to earlier diagnosis of colorectal cancer, potentially improving patient outcomes and survival rates.
How similar studies have gone: While there have been studies exploring blood tests for cancer detection, this specific approach combining molecular markers and clinical data is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients over the age of 18 who are able to understand the participant information and sign the informed consent. * Patients who are going to undergo colonoscopy or surgical resection for tumor (CRC). Exclusion Criteria: * Patients who had developed any type of cancer in the 5 years prior to their participation in this study. * Patients who have received previous chemotherapy or radiotherapy. * Patients diagnosed with non-advanced adenomas, serrated polyps, Familial Adenomatous Polyposis or Lynch Syndrome. * Patients with inadequate bowel preparation for colonoscopy. * Patients who have undergone colonoscopy/polipectomy in the previous 5 years. * Patients with hemolyzed plasma.
Where it's running
-
Hospital Clinico Universitario Lozano Blesa
Zaragoza, Aragon, Spain Recruiting -
Hospital Universitario de Cruces
Bilbao, Basque Country, Spain Recruiting -
Hospital Universitario de Salamanca
Salamanca, Castille and León, Spain Recruiting -
Hospital Centro Médico de Asturias
Oviedo, Principality of Asturias, Spain Recruiting -
Policlinica Gipuzkoa Hospital
Donostia / San Sebastian, Basque Country, Spain Completed -
Hospital Universitario Marques de Valdecilla
Santander, Cantabria, Spain Terminated
Show 3 more locations
-
Hospital Sant Rafael
Barcelona, Catalonia, Spain Completed -
Hospital Universitario Vall d' Hebron
Barcelona, Catalonia, Spain Completed -
MD Anderson Cancer Centre
Madrid, Madrid, Spain Active not recruiting
Study contacts
- Study coordinator: Marta Jimenez
- Email: mjimenez@amadix.com
- Phone: +34637899149
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Exercise after pelvic radiation to see if it lowers colorectal cancer risk
This study tests whether regular walking therapy after pelvic radiation for prostate cancer can influence markers of colorectal cancer in colon tissue and blood.
-
Irreversible Electroporation for Recurrent Pelvic Tumors
This study tests whether using irreversible electroporation (IRE) is safe and helps control recurrent pelvic tumors in adults who can’t have other local treatments.
-
Smart Symptom Tracking with ALEX for GI Health in Young Adults
This trial tests whether the Smart Symptom Tracking ALEX app can better track GI symptoms in young adults (18–44) compared with standard paper logs.
-
Culturally adapted online genetic counseling and testing education for African American cancer survivors
We will test a culturally adapted online genetic counseling program to see if it increases genetic counseling and genetic testing among African American breast, prostate, and colorectal cancer survivors.
-
Zanidatamab given before surgery for HER2-positive colon or rectal cancer
This tests whether giving zanidatamab before surgery helps adults with HER2-positive, RAS‑wildtype colon or rectal cancer who are planned for curative treatment.
-
In-home cancer treatment with remote specialist support for patients in the Florida Panhandle
This program will try giving standard cancer treatments at home to people living in the Florida Panhandle and nearby areas to see if they prefer it and have better treatment satisfaction.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.